Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma
Clinical trial NCT05561816 · COMPLETED
Trial details
- NCT number
- NCT05561816
- Sponsor
- Valenta Pharm JSC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-19
- Primary completion
- 2022-11-28
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.